Dr. Reddy's Laboratories Limited

PPFAS Mutual Fund increased its stake in Dr. Reddy's Laboratories from 1.73% to 1.76%, buying 602,782 shares. This position is worth ₹35.79 Cr based on the company's share price of ₹1206.00.

A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.

Founded by Parag Parikh Financial Advisory Services, best known for the Parag Parikh Flexi Cap Fund which invests in both Indian equities and select global large-caps including Meta, Alphabet, and Microsoft. Manages over Rs 1.2 lakh crore with a concentrated, long-duration, value-focused approach. CIO Rajeev Thakkar is one of India's most respected investors with a Munger-influenced thinking style.